AIM - AIM ImmunoTech Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 568M
Enterprise Value 317.95M
Trailing P/E N/A
Forward P/E 1-2.66
PEG Ratio (5 yr expected) 1-0.03
Price/Sales (ttm)206.07
Price/Book (mrq)1.24
Enterprise Value/Revenue 354.38
Enterprise Value/EBITDA 6-1.60

Trading Information

Stock Price History

Beta (5Y Monthly) -0.73
52-Week Change 3-62.19%
S&P500 52-Week Change 3-8.39%
52 Week High 314.8106
52 Week Low 30.3810
50-Day Moving Average 32.0224
200-Day Moving Average 31.0391

Share Statistics

Avg Vol (3 month) 38.23M
Avg Vol (10 day) 37.76M
Shares Outstanding 525.57M
Float 6.88M
% Held by Insiders 12.16%
% Held by Institutions 12.21%
Shares Short (Mar 12, 2020) 41.83M
Short Ratio (Mar 12, 2020) 40.12
Short % of Float (Mar 12, 2020) 479.56%
Short % of Shares Outstanding (Mar 12, 2020) 47.17%
Shares Short (prior month Feb 13, 2020) 41.01M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:44
Last Split Date 3Jun 10, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019


Profit Margin 0.00%
Operating Margin (ttm)-3,628.79%

Management Effectiveness

Return on Assets (ttm)-39.75%
Return on Equity (ttm)-98.13%

Income Statement

Revenue (ttm)330k
Revenue Per Share (ttm)0.19
Quarterly Revenue Growth (yoy)60.50%
Gross Profit (ttm)-517k
EBITDA -11.23M
Net Income Avi to Common (ttm)-9.95M
Diluted EPS (ttm)-5.8730
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)11.73M
Total Cash Per Share (mrq)1.42
Total Debt (mrq)6.91M
Total Debt/Equity (mrq)49.92
Current Ratio (mrq)3.01
Book Value Per Share (mrq)2.14

Cash Flow Statement

Operating Cash Flow (ttm)-9.2M
Levered Free Cash Flow (ttm)-6.08M